DermaGold
DermaGold is an extracorporeal shock wave therapy (ESWT) device that produces a biological response that encourages angiogenesis and promotes wound healing.
SoftWave Tissue Regeneration Technologies
SoftWave Tissue Regeneration Technologies is a bio-medical technology company that manufactures DermaGold, an FDA-cleared device for the treatment of diabetic foot ulcers and second-degree burn wounds.
Toll free:(888) 862-6162
Website:
www.softwavetrt.com
Benefits
• Non-invasive and non-surgical treatment
• Supports faster healing time
• Convenient for patient and provider
• Biological response includes growth-factor upregulation, inflammatory modulation and improved micro-vascularization and micro-circulation
Indications
DermaGold is indicated for use on diabetic foot ulcers and second-degree burns.
Contraindications
Do not use on on the lung and head area, on patients with malignancies, coagulation disorders, children, pregnant patients, wounds greater than 16sq cm, on patients with a BMI greater than or equal to 40 or patients on dialysis.
Adverse Effects/Reactions
Reddening, bruising, tingling, numbness, brief increase of pain is possible, as well as infection of the wound or beyond the wound.
Storage Requirements
Store at room temperature.
Product features
Contact manufacturer for more details
Other features
Educational Material Available
Free Samples/Trials Available
Published Clinical Article Available
Recommended Use
Burns
Diabetic Foot
Warranty
Five years
No posters match your selected filters. Remove some filtres, or reset them and start again.
Have a product to submit?
Be included in the most comprehensive wound care products directory
and online database.
Learn More